Palantir Partners with University of Colorado Anschutz Medical Campus to Establish the All of Us Research Program’s Center for Linkage and Acquisition of Data (CLAD)
11 Janeiro 2024 - 8:59AM
Business Wire
Palantir Technologies Inc. (NYSE: PLTR) today announced its
partnership with the University of Colorado Anschutz Medical Campus
to establish the Center for Linkage and Acquisition of Data (CLAD)
as part of the National Institutes of Health’s (NIH) All of Us
Research Program. All of Us is a historic research effort to drive
new scientific discoveries and advance precision medicine and
research. The center will connect new types of information to All
of Us participant data to help researchers better understand the
drivers of health and disease.
Unlike research studies that focus on a singular disease or
group of people, the All of Us program is informing thousands of
studies on a variety of health conditions. The University of
Colorado Anschutz Medical Campus, Palantir and other partners will
work with All of Us to configure a secure platform for processing
new data streams.
The CLAD team will be responsible for securely integrating
health care claims and mortality data, as well as initial
environmental data based on the Centers for Disease Control and
Prevention’s Environmental Justice Index. CLAD awardees will also
explore ways to overcome the technical challenges associated with
linking electronic health record (EHR) data from health information
networks for participants who have consented to share this
information. While most participants agree to share EHR data, the
program is seeking ways to improve data completeness using national
health information exchange standards.
“The approach to data collection for the Center for Linkage and
Acquisition of Data will allow the program to maximize
participants’ data and expand the utility of the All of Us dataset
without asking more of our participants,” said Chris Lunt, chief
technology officer of the All of Us Research Program. “This will
enable All of Us data to answer questions researchers don’t yet
have the means to investigate.”
As part of this effort, Palantir’s software will serve as the
interoperable, digital backbone of the CLAD platform, securely
connecting these new types of information to All of Us participant
data to provide researchers more information to better understand
the factors that influence health. Palantir’s software is able to
securely ingest, harmonize, evaluate, and assess the quality of the
new data sources, while also providing best-in-class governance and
security controls to ensure data protection and privacy.
“We originally began our partnership with the University of
Colorado Anschutz Medical Campus at the NIH in May of 2020 through
our work as the secure data enclave for the National Covid Cohort
Collaborative (N3C) program. Recognizing that critical health
outcomes require close collaboration across the health care
ecosystem, we're honored to partner with peers across government,
industry, and academia to support the All of Us Research Program,”
said Hirsh Jain, Head of Public Health, Federal, Palantir. “This
program has the potential to dramatically improve health outcomes
and we are excited to be a part of the team.”
“We are thrilled to become part of the All of Us Research
Program family. CLAD represents an unprecedented and innovative
partnership to leverage real-world data to improve health and
health equity. Palantir’s Foundry Platform will allow us to
securely integrate, harmonize, clean, and assess these varied data
types and explore novel approaches to analyzing them that can
accelerate future research,” said Melissa Haendel, Ph.D., Marsico
Chair in Data Science and Chief Research Informatics Officer at the
University of Colorado Anschutz Medical Campus, and Principal
Investigator for CLAD.
After an initial 18-month base period, the award may be renewed
annually for up to four additional years so the team can continue
to build on this work and include additional data streams for
research. The University of Colorado Anschutz Medical Campus,
Palantir, and its partners were selected following an extensive and
competitive process. Palantir’s work on the All of Us Research
Program’s Center for Linkage and Acquisition of Data is funded by a
subaward from the University of Colorado Anschutz Medical Campus,
which is funded by National Institutes of Health award
OT2OD036113.
All of Us, the All of Us logo, and “The Future of Health Begins
with You” are service marks of the U.S. Department of Health and
Human Services.
About Palantir Technologies Inc.
Foundational software of tomorrow. Delivered today. Additional
information is available at https://www.palantir.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. These statements may relate to, but are not limited to,
Palantir’s expectations regarding the amount and the terms of the
contract and the expected benefits of our software platforms.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted or quantified.
Forward-looking statements are based on information available at
the time those statements are made and were based on current
expectations as well as the beliefs and assumptions of management
as of that time with respect to future events. These statements are
subject to risks and uncertainties, many of which involve factors
or circumstances that are beyond our control. These risks and
uncertainties include our ability to meet the unique needs of our
customer; the failure of our platforms to satisfy our customer or
perform as desired; the frequency or severity of any software and
implementation errors; our platforms’ reliability; and our
customer’s ability to modify or terminate the contract. Additional
information regarding these and other risks and uncertainties is
included in the filings we make with the Securities and Exchange
Commission from time to time. Except as required by law, we do not
undertake any obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future developments, or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240111145948/en/
Lisa Gordon media@palantir.com
Palantir Technologies (NYSE:PLTR)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Palantir Technologies (NYSE:PLTR)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024